Serophene Active Pharmaceutical Ingredient API Clomifene Citrate Clomid 50-41-9

Serophene Anti Cancer powder steroids Of Clomifene Citrate Clomid CAS 50-41-9

Specification:

Name:Clomifene citrate (clomid)

English synonyms:Serophene;Pergotime;Clomphid;Clomid;Clomifene citrate;Clomiphene citrate;

Clomiphene citrate salt;2-[4-(2-chloro-1,2-diphenylethenyl)-phenoxy]-n,n-diethylethanamine citrate salt

NO.: 50-41-9

EINECS: 200-035-3

Molecular Formula:C32H36ClNO8

Molecular Weight:598.08

Quality Standard: USP

Assay: 98%

Appearance: White or white crystalline powder. Melting point 116.5-118, slightly soluble in ethanol, chloroform, water

Usage: The product is anti-estrogen (fertility inducing object), in dysfunctional uterine bleeding,
polycystic ovary, menstrual disorders, and drug-induced amenorrhea and other gynecological diseases.
Packing:1kg/foil bag or as required.

Detailed information:

Clomid is available in 50 mg tablets. Treatment of the selected patient should begin with a low dose, 50 mg daily (1 tablet) for 5 days; dose changes are made by the treating physician. The first dose should occur on the 5th day of the female's ovulatory cycle and then subsequent doses at about the same time of day for a total of 5 days. Patients should be familiar with their ovulatory cycle so that properly timed coitus and ovulation stimulated by the drug occur.

Application:

Stop taking clomiphene and seek emergency medical attention if you experience an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives).

The ovarian hyperstimulation syndrome (OHSS) has been reported to occur in patients receiving clomiphene. Symptoms of OHSS include swelling of the hands or legs, abdominal pain and swelling, shortness of breath, weight gain, and nausea or vomiting. OHSS can be fatal. Notify your doctor immediately or seek emergency medical attention if you develop any of these side effects.